TMCnet News

North America Molecular Diagnostics Market 2016-2022 - Research and Markets

[May 26, 2017]

North America Molecular Diagnostics Market 2016-2022 - Research and Markets

Research and Markets has announced the addition of the "North America Molecular Diagnostics Market (2016-2022)" report to their offering.

Molecular Diagnostics are used to identify or monitor biomarkers associated with any particular diseases or conditions. Tests can also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into Instruments, Reagents & Kits, and software & services. Reagents & Kits are expected to gather the largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, maket is segmented into Polymerase Chain Reaction (PCR (News - Alert)), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into US, Canada and Mexico.

Key Topics Covered:

1. Market Scope & Methodology

2. Executive Summary

3. Market Overview

4. North America Molecular Diagnostics Market

5. North America Molecular Diagnostics Market by Technology

6. North America Molecular Diagnostics Market by Application

7. North America Molecular Diagnostics Market by End User

8. North America Molecular Diagnostics Market by Country

9. Company Profiles

- Abbott Laboratories

- Qiagen N.V.